Cite
Interleukin-10 activation of the interleukin-10E1 pathway and tissue inhibitor of metalloproteinase-1 expression is enhanced by proteasome inhibitors in primary prostate tumor lines.
MLA
Stearns, Mark E., et al. “Interleukin-10 Activation of the Interleukin-10E1 Pathway and Tissue Inhibitor of Metalloproteinase-1 Expression Is Enhanced by Proteasome Inhibitors in Primary Prostate Tumor Lines.” Molecular Cancer Research : MCR, vol. 1, no. 9, July 2003, pp. 631–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12861049&authtype=sso&custid=ns315887.
APA
Stearns, M. E., Wang, M., Hu, Y., & Garcia, F. U. (2003). Interleukin-10 activation of the interleukin-10E1 pathway and tissue inhibitor of metalloproteinase-1 expression is enhanced by proteasome inhibitors in primary prostate tumor lines. Molecular Cancer Research : MCR, 1(9), 631–642.
Chicago
Stearns, Mark E, M Wang, Youji Hu, and F U Garcia. 2003. “Interleukin-10 Activation of the Interleukin-10E1 Pathway and Tissue Inhibitor of Metalloproteinase-1 Expression Is Enhanced by Proteasome Inhibitors in Primary Prostate Tumor Lines.” Molecular Cancer Research : MCR 1 (9): 631–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12861049&authtype=sso&custid=ns315887.